Lyric Pharmaceuticals
Latest round
- Series A
Last raised
- Apr 2017
Total raised
- $40M
Investors
- 4
About Lyric Pharmaceuticals
Established in 2013 and based in California, US, Lyric Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel gastrointestinal therapeutics including LP101 (ulimorelin). In April 2017, Lyric Pharmaceuticals Inc.
Who invested in Lyric Pharmaceuticals
4 investors across 3 rounds
See all investors in Lyric Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lyric Pharmaceuticals
Who invested in Lyric Pharmaceuticals?
Lyric Pharmaceuticals has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lyric Pharmaceuticals raised?
Lyric Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Lyric Pharmaceuticals last raise money?
Lyric Pharmaceuticals's most recent round on record is a Series A, in Apr 2017.
What does Lyric Pharmaceuticals do?
Established in 2013 and based in California, US, Lyric Pharmaceuticals, Inc.
Where is Lyric Pharmaceuticals headquartered?
Lyric Pharmaceuticals is headquartered in San Francisco, US.
Which VCs invest in companies like Lyric Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lyric Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Lyric Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.